Phytoestrogens are plant derivatives with estrogen-like effects that are able to bind to human estrogen receptors (ER). Phytoestrogens are found in high amounts for example in soybeans, so the effects of soy isoflavonoids (daidzein, genistein and glycitein) have been extensively studied in recent years. These soy isoflavonoids (Fig. 1) can be alternatives to conventional hormone therapy in postmenopausal women (Aso, 2010; Messina, 2014) , because they bind to the human estrogen receptors, despite their non-steroidal structures (Vitale et al., 2013) . estradiol. These isoflavonoids show non-steroidal structure, however, they are able to bind to the human estrogen receptors (Wood CE et al., 2006) .
Plant sterols are important materials for insects to synthesize their own hormones. From phytosterols, honeybees are able to produce ecdysteroids that regulate molting, metamorphosis and reproduction (Fig. 2) . These ecdysteroids are also synthesized by the honeybee queen ovaries (Hartfelder et al., 2002) . Ecdysteroids such as 20-hydroxyecdysone show protein synthesis-stimulating effect in mammals, but its androgenic effect is absent (Bathori et al., 2008) .
Phytoestrogens are widely known, but the concept of phytoandrogens is relatively new (Edouard et al., 2014) . Ong & Tan reported the androgenic effect of Eucommia ulmoides cortex as a novel phytoandrogen compound (Ong & Tan, 2007) . This phytoandrogenic activity was being mediated by triterpenoids and surprisingly, synergistic effect was observed, when Eucommia ulmoides extract and dihydrotestosterone were used in combination. Besides of these facts, several natural substances with androgenic activity have been reported and these extracts and compounds are predominantly used as aphrodisiacs. Korean Red ginseng extract can be an effective alternative therapy for treating erectile dysfunction (ED) (Choi et al., 1999; Jang et al., 2008) . It can act through multiple mechanisms, the relaxing effect might be mediated by NO production, but it is not related to sexual hormone levels (de Andrade et al., 2007; Cho et al., 2013) . The other aphrodisiac is the yohimbine, an  2 -adrenocepor antagonist (from Rauwolfia serpentina), which can be also effective in the treatment of ED (Tam et al., 2001) . The mechanism of yohimbine action in regulating ED, is a combined effect on the central nervous system and peripheral effects (Saad et al., 2013) .
However, there are a lot of plants or extracts of plants, which can be used as aphrodisiacs, for example Turnera diffusa extract (Estrada-Reyes et al., 2009 ) and nowadays very intensively investigated Tribulus terrestris extract (Gauthaman et al., 2002; Chhatre et al., 2014) . The effects of all of these compounds and extracts were utilized first in folk medicine and were later proved by evidence-based medicine, and the majority of them are currently available as medical products.
Honeybee products in medicine
Numerous honeybee (Apis mellifera) products, such honey, propolis and bee venom, have been used in traditional medicine to prevent or treat illness and promote healing. The honey has been used since ancient times as part of traditional medicine for the treatment of common cold (Allan & Arroll, 2014) and cough (Paul et al., 2007) and is used in modern medicine to treat wounds (Majtan, 2014) , among other uses. The other, widely investigated honeybee product is the propolis. Propolis provides several beneficial effects on human health, it shows for example antifungal, antibacterial and anti-inflammatory activity (Wagh, 2013) . Bee venom also has been used in traditional medicine to treat diseases, such as arthritis, pain, tumors and skin diseases via its anti-inflammatory, antinociceptive and anticancer activities (Son et al., 2007; Oršolić, 2012) .
Nowadays, one of the most intensively studied beehive products is the royal jelly (RJ). RJ is the essential food for the queen bee pupa and the queen and it is secreted by the hypopharyngeal and mandibular glands of worker honeybees. It is known, that the fertility of honeybees is mainly driven by the quality and quantity of their food, accordingly when bee larvae are nourished with RJ, they differentiate into queens. The adult queens also consume a high amount of RJ, which contributes to the maintenance of their fertility (Kamakura, 2011; Remolina & Hughes, 2008) . These facts and the traditional usage of RJ in the treatment of menopausal symptoms suggested that RJ may possibly have some estrogen-like effect. In fact, in vitro and in vivo estrogenic effects of raw RJ have been described (Mishima et al., 2005) and its isolated effective compounds (10-hydroxy-trans-2-decenoic acid and its derivatives) exhibit weak ER binding affinities (Suzuki et al., 2008) .
Drone milk
Drone milk (DM) is a relatively little-known honeybee product that is secreted (similarly to RJ) by the hypopharyngeal and mandibular glands of the worker honeybees. DM is main component of drone brood which also contains larvae and pupae of drones in the comb (Mutsaers et al., 2005a) . DM is a light yellow, slightly sweet, thick liquid which is separated from drone brood by extraction to eliminate larvae and pupae during the harvest.
DM is an essential food of the drone larvae and drone honeybees, and its consumption is presumed to be related to the fertility of drones. Although our knowledge of the effects of DM is very limited, a drone brood preparation is traditionally used in Romania for the rehabilitation and activation of aged people and to treat neurovegetative and sexual problems (Bogdanov, 2011) . Data have been reported on the hormone-like strengthening effects of the drone larvae and brood in Eastern European and Asian folk medicine (Mutsaers et al., 2005b) and Yucel et al. have described the androgenic and anabolic effects of Apilarnil (drone bee larvae) on male broilers (Yucel et al., 2011; Altan et al., 2013) .
The folk medicine experience and the previously described data suggest the putative hormone-like activity of DM.
Aims
The purpose of this work was to investigate the sexual hormone-like effects of DM on rats and to confirm the folk medicine experience. Therefore the following aims were set:
1.
The primary aim of this work was to investigate the androgenic effect of raw DM in castrated rats using Hershberger assay. 
Collection of drone milk
DM was prepared during rape blooming and harvested by the separation from drone larvae and pupae in the late spring (the middle of May) by Sándor Polgár (a professional Hungarian beekeeper). DM -similarly to honey -is extracted from the comb using centrifugal force. The raw liquid material was divided into plastic tubes and was stored at -20 °C until the beginning of the investigation and it was diluted with distilled water in all animal experiments.
Investigation of androgenic effect

Hershberger assay
Androgenic activity was investigated by a simplified Hershberger assay (Freyberger et al., 2007; Tinwell et al., 2007; Moon et al., 2009) . Mature male Sprague-Dawley rats (230-240 g)
were anesthetized through the inhalation of 3% isoflurane vapor (Abbott Laboratories, Abbott
Park, IL, USA) via a Burtons anesthetic machine (Guardian Industrial Estate, Marden, U.K.).
Castration was performed animals underwent surgically, and the animals were treated locally with pefloxacine to avoid infective complications. Pefloxacine injection (Peflacine®) was purchased from EGIS Pharmaceutical Industry, Budapest, Hungary.
After 10 days, healthy rats were assigned to 6 groups (n=18 per group) by body weight. Body weights were recorded on days 1, 4, 7 and 10 of the study. The animals were treated with the investigated compounds once daily for 10 consecutive days. Testosterone (Sigma Aldrich, Budapest, Hungary) was dissolved in olive oil. When methyl palmitate (MP) and methyl oleate (MO) (Sigma Aldrich, Budapest, Hungary) were involved in the simplified Hershberger assay, the compound was administered in olive oil by oral gavage. Flutamide (Sigma Aldrich, Budapest, Hungary) was suspended in mucilage methylcellulose (0.5%;
Sigma Aldrich, Budapest, Hungary). In a preliminary experiment, DM was administered at three doses (11, 110 or 1100 mg/kg/day), and it was found that the 110 mg/kg/day dose led to increases in the weights of androgen-sensitive organs. The administration protocol for the raw DM administration is outlined in Table 1 . 
Plasma testosterone assay
Before the exsanguinations, 1 mL of blood was taken from each of 5 animals in each group by cardiac puncture under deep isoflurane anesthesia. Blood samples were collected in BD Vacutainer tubes (Belliver Industrial Estate, Plymouth, UK) and centrifuged (CR-132, Jouan, Saint-Herblain, France) at 1500 g for 10 min to separate the plasma. Plasma samples were stored at -70 °C until assay. Plasma testosterone levels were determined with a testosterone EIA kit (Cayman Chemical Company, Ann Arbor, MI, USA). Absorbancies were measured with a SPECTROstar Nano microplate reader (BMG Labtech, Offenburg, Germany).
Determination of prostatic Slap mRNA by real-time RT-PCR
Mature male Sprague-Dawley rats (400-420 g) were castrated. After 7 days, healthy rats were randomized and assigned to 3 groups (n=5 per group) by body weight. The animals were treated once daily for 5 consecutive days with DM (110 mg/kg orally) or testosterone (1.67 mg/animal subcutaneously). The control group was treated with the vehicle of the DM (distilled water) orally. One day after the final treatment, the rats were sacrificed, and ventral prostate tissues were removed and frozen in liquid nitrogen.
The tissues were homogenized mechanically. Total RNAs from tissues were extracted by using a TRIsure Kit (Bioline Reagents Ltd., London, UK). The quality and quantity of the RNA were assessed at wavelengths of 260/280 nm, and all samples exhibited an absorbency ratio in the range 1.6-2.0.
1 g of total RNA and the TaqMan RNA-to-CT 1-Step Kit (Applied Biosystems, Budapest, Hungary) were used for reverse transcription and amplification. The following primers were used: assay ID Rn01756639_g1 (Amplicon Length: 71) for Slap and Rn99999916_s1 for β-actin as endogenous control. RT-PCR was performed with an ABI StepOne Real-Time cycler (Applied Biosystems, Budapest, Hungary). The fluorescence intensities of the probes were plotted against PCR cycle numbers. The amplification cycle displaying the first significant increase in the fluorescence signal was defined as the threshold cycle (CT).
Western blot analysis
Mature male rats (320−350 g) were castrated and treated as described previously (section 3.3.3) . Ventral prostate tissues were powdered with a Sartorius Mikro Dismembrator U (Sartorius, Goettingen, Germany) and homogenized in RIPA Lysis Buffer combined with PMSF solution, sodium orthovanadate solution and protease inhibitor cocktail solution (Santa Cruz Biotechnology Inc., Santa Cruz, CA, USA). Samples were centrifuged at 100,000 x g for 1 h, and the supernatant was used to measure total protein (cytosolic fraction). The precipitate was resuspended in the original volume of the buffer and was used as a total membrane fraction. 50 g of protein per well was subjected to electrophoresis on 4−12% NuPAGE BisTris Gel in XCell SureLock Mini-Cell Units (Life Technologies, Budapest, Hungary).
Proteins were transferred from gels to nitrocellulose membranes by using the iBlot Gel 
Bioactivity-guided fractionation
The crude DM was diluted with water (165 mL), extracted with petroleum ether (5 x 200 mL) and re-extracted with water (3 x 10 mL). The combined aqueous phase was applied to an octadecyl-silica column (250 g, 0.06−0.02 µm; ChemieUetikon-C-Gel, Chemie Uetikon, Uetikon am See, Switzerland) and subjected to low-pressure reversed-phase column chromatography (RPCC). Gradient elution was performed with water, 20% (I/A), 40%, 60%
and 80% (I/B) aqueous methanol (MeOH; 700 mL each), 100% MeOH (I/C, 1000 mL) and dichloromethane (I/D, 1000 mL).
Fractions I/B and I/C eluted from the reversed-phase column with MeOH were evaporated to dryness. The residues of I/B (0.0143 g) and I/C (0.94 g) were dissolved in 50% aqueous acetone and further fractionated through repeated low-pressure RPCC (20 g, LiCroprep RP-18 40-63 µm, E. Merck, Darmstadt, Germany). To determine the elution range of the sample constituents, a pre-chromatographic separation with a small sample on RPCC was used and the androgenic activity of the fraction was controlled by real-time RT-PCR, as described above (section 3.3.3). The active constituents of I/B and I/C were eluted with 75% aqueous acetone. Unfortunately, the separation products of fraction I/B were found later to be ineffective, and the codes of these products are therefore not mentioned further. The whole of fraction I/C was separated. The elution was started with a weaker solvent system than 75% aqueous acetone (70% aqueous acetone (II/A) 200 mL) and this was followed by 75% aqueous acetone (II/B, II/C, II/D and II/E). A large volume of this latter solvent system (900 mL) was used to the elution. Finally, the column was washed with acetone (II/F) (150 mL) and dichloromethane (150 mL). The active fraction (II/E) eluted with 75 % aqueous acetone was evaporated to dryness and the residue (0.0669 g) was analyzed by thin-layer chromatography (TLC), MS and NMR. The whole separation procedure was controlled by RP TLC (TLC systems 1 and 2). RP TLC was performed on 20 x 20 cm glass TLC plates coated with RP-18WF254 (E. Merck, Darmstadt, Germany) at room temperature by an ascending technique with a mobile phase: TLC system 1: acetone-water (95 : 5 v/v), TLC system 2:
tetrahydrofuran-water (7 : 3 v/v). The separation was detected by the use of a vanillin-sulfuric acid spray reagent. The quantities of the residues and their doses for oral administration are shown in Table 2 . 
Statistical analysis
Statistical analyses were performed with the Prism 4.0 software. All body and organ weights, plasma testosterone data, mRNA and protein expressions of SLAP were analyzed by one-way ANOVA, followed by Dunnett's test, and each is presented as the mean ± standard error of the mean (SEM). Significance was accepted at p<0.05.
Investigation of estrogenic effect
Uterotrophic assay
Uterotrophic assays were performed in accordance with the protocol described by Kanno et al. and Song et al. (Kanno et al. 2001; Song et al. 2002 One day after the final treatment, the rats were sacrificed, their uteri were removed and weighed. Uterus weights were expressed as relative weights (organ weight mg/100 g body weight).
Determination of C3 mRNA by real-time RT-PCR
Mature female rats (160−180 g) were ovariectomized under isoflurane anesthesia 8 days prior to treatment. The animals were randomly grouped (n=6) and were treated once daily for 2 days with E 2 (96.2 μg/kg/day), DM (0.5 g/ kg/day) or vehicle only. One day after the final treatment, the rats were sacrificed by exsanguination under deep isoflurane anesthesia. The uteri were removed, trimmed free of fat and adjacent tissue. The uterus samples were stored at 4 °C overnight in RNAlater solution (Life Technologies, Budapest, Hungary), the supernatant was then removed, and the samples were stored at -70 °C until the beginning of the investigation. For amplification, the following conditions were used: 50 °C for 2 min, 95 °C for 10 min and 40 cycles of 95 °C for 15 sec, 60 °C for 1 min. The fluorescence intensities of the probes were plotted against PCR cycle numbers. The amplification cycle displaying the first significant increase in the fluorescence signal was defined as the CT.
Group
Western blot analysis
Mature female rats (160−180 g; n=6 in each group) were ovariectomized and treated as described previously (section 3.4.2). Uterus tissues were used to isolate total protein using the As already mentioned, the whole separation procedure was controlled by RP TLC and the compounds were detected by the use of a vanillin-sulfuric acid spray reagent. Table 4 shows the administration protocol of bioactivity-guided fractions. The control groups (n=10) were treated with either 0.5% MM or olive oil. 
HRMS and NMR analyses
HRMS analyses were performed on an LTQ FT Ultra (Thermo Fisher Scientific, Bremen, Germany) spectrometer. Ionization was achieved with ESI, operated in the positive ion mode.
The ion transfer capillary temperature was set at 280 °C, and the capillary voltage for each measurement was 4.1 kV. In CID (collision-induced dissociation) experiments, helium was used as the collision gas, and normalized collision energy (expressed as a percentage), which 
Statistical analysis
All statistical analyses for biological determinations (uterotrophic assay, RT-PCR and
Western blot) were performed with the Prism 4.0 software. All data were analyzed by oneway ANOVA followed by the Newman-Keuls test and each value is reported as a mean ± SEM. Significance was accepted at p<0.05.
Investigation of gestagenic effect
Pregnancy maintenance assay
Mature female (160-180 g) and male (220-240 g) Sprague-Dawley rats were mated in a special mating cage. The presence of pregnancy was determined by the assessment of sperm in the vaginal smear (first day of pregnancy). On day 8 of the pregnancy, the animals were ovariectomized and the numbers of fetuses (implantation sites) were registered. The ovariectomized females were randomly assigned to 3 groups (n=7) and were treated with the test compounds once daily from day 8 to day 14. On day 15 of pregnancy, the number of surviving fetuses was recorded and was given as a ratio of all fetuses (Arkaravichien & Kendle 1990; Elger et al., 2003) .
RT-PCR and Western blot measurements
Mature female rats (160−180 g) were ovariectomized under isoflurane anesthesia 6 days prior to treatment. The animals were randomly grouped and were treated once daily for 3 days with DM (0.5 g/kg/day) or progesterone (P; 2x2 mg/day) or vehicle (distilled water) only. Later, the other group of animals was treated with the weak gestagen spironolactone (SP; 2x15 mg/kg/day) and with a combination of DM (0.5 g/kg/day) and SP (2x15 mg/kg/day). One day after the final treatment, the rats were sacrificed and their uteri were removed.
The isolation of total RNA and the amplification of the PCR products CRLR (Rn00562334_m1) and GAPDH primer (Rn99999916_s1) as endogenous control were performed as previously mentioned (section 3.4.2).
The isolation of protein for the Western blot measurement was performed as described previously (section 3.3.4), using CRLR and -ACTIN polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA; 1:200) in the blocking buffer.
Statistical analysis
All statistical analyses for biological determinations (pregnancy maintenance assay, RT-PCR and Western blot) were performed with the Prism 4.0 software. All data were analyzed by one-way ANOVA followed by the Dunnett's test and each value is reported as a mean ± SEM.
Significance was accepted at p<0.05.
Results
Androgenic effect of drone milk
In vivo androgenic effect of crude drone milk
No treatment-related symptoms or abnormal changes were observed in any of the groups.
There was no significant difference between the increases in body weight of the crude DMtreated and non-treated (control) groups. Testosterone treatment increased the body weight as compared with the other groups. Flutamide blocked the body weight-increasing effect of testosterone, but alone did not influence the gain in weight (Fig. 3) . The raw DM increased the relative organ weights (wet organ weight mg/100 g body weight)
of the glans penis, seminal vesicle and levator ani muscle in rats. It also increased the average prostate weight, though this change was not statistically significant. Testosterone enhanced all the organ weights, and was more effective than the DM. The organ weights were not changed by flutamide treatment, but flutamide inhibited the organ weight-increasing effect of the DM and blocked the effects of testosterone (Fig. 4) . 
Measurement of plasma testosterone level
Both the raw DM and the testosterone treatment increased the plasma testosterone level.
Flutamide treatment blocked the plasma testosterone level-increasing effects of both compounds. After a single administration of flutamide, the hormone level remained unchanged (Fig. 5) . 
Measurements of prostatic Slap mRNA and protein
The crude DM increased the expression of Slap mRNA in ventral prostate, but this effect was significantly lower than that of testosterone. In Western blot measurements, DM was found to increase the level of SLAP in the ventral prostate tissue (Fig. 6) . 
Bioactivity-guided fractionation
After clarification of the androgen-like effect of raw DM, we launched bioactivity-guided fractionations to find the effective ingredients of this natural product. As an initial step of DM purification, liquid-liquid partition was used with a high load. The crude DM was extracted with petroleum ether after dilution with water, to remove apolar contaminants. This prepurified extract was separated by a multistep chromatographic method, applying RPCC twice.
The purification was based on the differences in sample load throughout the chromatographic process. In the first RPCC separation, the column was highly loaded and a multistep gradient was used, but each gradient step was large. Two of the four fractions gained (I/B and I/C) increased the mRNA level of Slap. The difference between the effects of the two fractions was non-significant (Fig. 7) .
C. In the second RPCC for fraction I/C, the ratio of load to sorbent was high (1:20) and the elution gradient steps were smaller. After each column chromatography step, the fractions with the same compositions were combined. One of the six fractions gained (II/E) increased the mRNA level of Slap (Fig. 8) . 
Identification of the androgenic compound(s) of raw drone milk
Fraction II/E was subjected to TLC, mass spectral (MS) and NMR analyses. In order to characterize the biologically active components fraction II/E was subjected to GC-HRMS and NMR spectroscopic investigation. The GC chromatogram indicated the presence of two main components in the sample (RT 9.03 and 9.73 min). (Hallgren et al., 1959; suggested (in accordance with the fragmentation characteristics) that the two main components were the well-known fatty acid methyl esters, MP and MO. These structural suggestions were confirmed by comparing the 1 H and 13 C NMR data with those available in the literature (Gunstone & Ismail, 1967; Couperus et al., 1978) , and by comparing the GC-HRMS chromatograms and spectra of the collected sample with those measured on the purchased compounds. These results unambiguously identified the two components present in the biologically active fraction II/E as MP and MO (Fig. 9) . After the isolation of MO and MP from fraction II/E, we investigated their contributions to the androgenic effect with our simplified Hershberger assay and plasma testosterone assay.
MO, MP and their specific combination (molar ratio: 4:3=MO:MP) were administered in doses of 2.5, 25 and 250 μg/kg. The 25 μg/kg dose of MP and the highest dose (250 μg/kg) of the MO and MP combination increased the weights of androgen-sensitive organs (except the prostate tissue). These androgenic effects, similarly to those of raw DM, were flutamidesensitive (Fig 10) . The results of ineffective doses are not shown.
A. B. Similarly to the crude drone milk, the compounds had no effect on the prostate (C). Testosterone (T) was used as positive control. *p<0.05; ** p<0.01; *** p<0.001; ns: not significant
The plasma testosterone level was not affected by either MO or MP in any of the applied doses. In contrast, when the combination was applied in the highest dose, an increase in plasma testosterone level was detected (Fig. 11) . 
Estrogenic effect of drone milk
In vivo estrogenic effect of crude drone milk
The estrogenic activity of raw DM was examined by means of uterotrophic assays. The adequacy of the model in our laboratory was proved by treatment with 17β-estradiol valerate (E 2 ). E 2 increased the relative weight of the uteri and this activity was diminished by the antiestrogenic ICI 182.780 (ICI). The raw DM was able to increase the relative weight of uteri and similarly to that of E 2 the estrogenic effect of DM was blocked in the presence of ICI. The soy extract also increased the weight of the uteri (Fig. 12) . 
Measurements of C3 mRNA and protein in rat uterus
By means of a real-time PCR technique, we found that DM almost doubled the relative C3 mRNA expression in the uteri. The effect of positive control E 2 was also significant (Fig. 13) . In Western blot measurement DM enhanced the level of C3 in the uterine tissue, and E 2 was also effective (Fig. 14) . The gel photo (B) reveals that the C3 protein is split into alpha and beta chains during Western blot studies; the densities of both chains were therefore evaluated (A). 
Bioactivity-guided fractionation
The crude DM was diluted with water and extracted with petroleum ether in order to remove apolar contaminants. The pre-purified extract was subjected to repeated RP CC. After the first separation, the fractions with the same compositions were combined and tested by uterotrophic assay (Fig. 15) . 
A. B.
Further separations were done with fraction I/C, but new fractions were ineffective in uterotrophic assay, therefore we did not continue the investigation of this product. On the basis of the results, the other two fractions (I/A and I/B) were chosen for further separation.
As the main constituent of the more active fraction (I/A) was also present in I/B, although the material content of the latter was much lower, these two fractions were combined and purified together by column cromatography (CC). The second CC separation, with the stationary phase in a high (e.g. 20-fold) excess, and elution of the constituents with a multistep gradient, proved to permit rather effective purification. The pharmacological experiments led to four fractions being subjected to further examination by uterotrophic assay (Fig. 16) . The correlations of the methylene and olefinic protons observed in the one-and twodimensional ZTOCSY spectra permitted the complete 1 H NMR assignment of the identified compound. The HSQC and HMBC spectra suggested the presence of two carboxylic groups, bound to C-2 and C-9 (H-2 and H-3 correlate with a carbon at 170.6 ppm, (C-1), and H-8 and H-9 correlate with a carbon at 177.8 ppm (C-10)). Structure of this compound, the E-dec-2-enedioic acid accords with the determined elemental composition of the main component (Fig. 17) . 
Gestagenic effect of drone milk
In vivo gestagenic effect of crude drone milk
The gestagenic activity of crude DM was investigated by means of pregnancy maintenance assays. The E 2 treatment (as negative control) led to the complete loss of pregnancy in ovariectomized pregnant rats, but the combination of E 2 and DM resulted in the survival of 17.4% of the fetuses. Although the number of surviving fetuses was increased, this effect was not statistically significant. The combination of E 2 and P (as positive control) displayed a well-defined pregnancy-maintaining effect, with a fetus survival rate of 98.8% (Fig. 18) . 
Measurements of CRLR mRNA and protein in rat uterus
The crude DM increased the expression of CRLR mRNA in the rat uterus, similarly to P.
Western blot measurements yielded similar results, DM treatment increased the level of CRLR protein. The representative gel photo shows the change in CRLR proteins together with GAPDH (Fig. 19) . 
Measurement of the gestagenic efficacy of drone milk
In our next experiment, we made use of the weak gestagenic compound SP. SP was used alone and in combination with DM. SP alone did not increase the expression of CRLR mRNA, but its combination with DM caused a marked increase in CRLR mRNA (Fig. 20) .
A. B.
C. The combination of DM and SP kept 21.4% of the fetuses alive, and (unlike the action of DM alone) this effect was significant (Fig. 21) . DM is a lesser-known honeybee product; it is a purified extract of drone brood without larvae and pupae and the main food of drone bees and larvae. DM and frozen drone larvae are used in folk medicine and are available as a dietary supplement and an aphrodisiac (Frozen drone larvae royal jelly®, Apidom Ltd, Russian Federation; Apilarnil Potent®, S.C. Biofarm S.A., Bucuresti, Romania). Since the folk medicine uses drone brood to treat sexual problems in both genders, we hypothesized that DM may have some hormonal effects, too. Therefore we searched for both male and female hormonal effect and the active components of DM.
This study first proved the androgenic effect of raw DM by its action to increase weight of the androgen-sensitive organs, except the prostate, in rats. Unlike testosterone, DM did not increase the body weights of the rats, suggesting that the material does not have pronounced anabolic activity. Apart from steroid hormones, no androgenic animal products are known in the scientific literature. The haemolymph of insects contain ecdysteroids, which demonstrate varied pharmacological effects in mammals. In contrast with DM, these compounds have anabolic effects (Dinan & Lafont, 2006; Toth et al., 2008) , but their androgenic effect is absent.
Surprisingly, the raw DM increased not only weight of the androgen-sensitive organs but also the plasma testosterone level in castrated rats. This result suggests that DM may induce the non-testicular synthesis of testosterone in rats. The antiandrogenic flutamide reduced the plasma testosterone level-increasing effect of DM. Flutamide is known to reduce the synthesis of androgens by inhibiting CYP17A1, which is responsible for dehydroepiandrosterone (DHEA) synthesis, and/or by increasing their metabolism (Moghetti et al., 2000) . The latter can explain the testosterone plasma level-reducing effect of flutamide followed by testosterone treatment. CYP17, the key enzyme of androgenesis is expressed predominantly in the gonads and is absent from the adrenal glands in rats (Brock & Waterman, 1999) .
However, it displays relatively high activity in the gastrointestinal tract and kidneys of rats.
DHEA is transformed to testosterone by 3-and 17-hydroxysteroid dehydrogenases (HSD), but these enzymes are significantly active in the testicular and renal tissues (Dalla Valle et al., 1995; Dalla Valle et al., 2004) . We therefore presume that DM may induce testosterone synthesis via the enzymes CYP17 and HSD in the renal tissues of castrated rats.
We set out to prove the androgenic effect of DM at a molecular level, targeting mainly the androgen-sensitive prostatic proteins in castrated rats. Although the increase in weight of the prostatic tissue response to DM was not significant, we attempted to determine whether the level of androgen-sensitive SLAP was altered or not by DM treatment. Both the mRNA and protein expression of SLAP proved to be increased in the rat prostate, which means that, in spite of the non-significant prostate weight-increasing effect of DM, the molecular consequences of its androgenic effect are detectable through the increase in prostatic SLAP level (Nishi et al., 2008) . This method was therefore used for further evaluation of the androgenic action of DM fractions.
Bioactivity-guided fractionation was performed to identify the compounds in DM responsible for its androgenic effect. Although we detected two effective fractions (I/B and I/C) after the first fractionation, the effect of fraction I/B was lost during the second fractionation. We therefore had to focus on the separation products of fraction I/C.
NMR and MS measurements after the second fractionation revealed MP and MO in the last active fraction (II/E) of the raw DM. Although MO alone had no effect on androgen-sensitive organs, MP (similarly to raw DM) increased the weights of the androgen-sensitive organs (except the prostate) and these effects were flutamide-sensitive. Palmitate is known to play a role in steroidogenesis: it is able to increase the DHEA level through its CYP17 activity (Bellanger et al., 2012) . A fatty acid infusion has been reported to elevate human androgen production in both sexes (Mai et al., 2006; Mai et al., 2008) . MP was proved to inhibit carrageenan-induced paw oedema by reducing the prostaglandin E2 level (Saeed et al., 2012) , an effect which might indicate a steroidogenesis-inducing property. Since DHEA alone has weak androgenic effect, the putative DHEA-elevating effect of MP may explain in part the response of androgen-sensitive organs. The androgenic dose (25 μg/kg) of MP alone did not alter the plasma testosterone level, but its combination with MO in high dose exhibited plasma testosterone-increasing effect, similarly to the action of raw DM. It is known that oleic acid has a weak 5--reductase inhibitory effect, preventing testosterone conversion to dihydrotestosterone, whereas the esterified analogues of oleic acid (like MO) are ineffective in this respect (Liu et al., 2009) . As yet we have no explanation as to why the combination of MP and MO increases the plasma testosterone level in rat. Nevertheless, we have clearly shown that these two compounds have a major role in the main androgenic action of DM.
Further studies are required to clarify the androgenic mechanisms of action of MO and MP.
Evidence of an estrogenic effect of drone milk
Since DM is produced by the worker bees that also prepare RJ, which contains special fatty acids with estrogenic activity, furthermore, DM and drone brood are used in both genders to treat sexual problems, we would like to determine the putative estrogenic effect of crude DM.
The raw DM was able to increase the relative organ weights of uteri in immature female rats and this effect was estrogenic antagonist (ICI 182.780) sensitive similarly to the action of E 2 .
This result indicates that the raw DM undoubtedly has an estrogenic activity. Although the extent of the weight-increasing effect of DM was moderate as compared with those of soy extract or E 2 , its estrogenic activity was still noteworthy, as the DM was unpurified material.
Besides the uterotrophic assay, we sought molecular markers with which to confirm the estrogenic effect of DM. C3 expression has been reported to be a molecular marker of estrogenic activity (Diel et al., 2000; Lundeen et al., 2001 ). The raise in the level of the mRNA and protein expression of C3 supports the results of uterotrophic assay. The changes in the uterine level of C3 protein are other evidences for the estrogenic effect of raw DM.
Similarly to the androgenic effect, bioactivity-guided fractionations were performed to identify the estrogenic compounds in raw DM. Through a three-step procedure we gained a fraction and identified the structure of one main compound. This fraction was different from the androgenic fraction (Fig. 22) . : fractionation for uterotrophic assay : fractionation for RT-PCR measurement of Slap By HRMS and NMR data the main component in fraction III/A is E-dec-2-enedioic acid, which is very similar to estrogenic fatty acids isolated from RJ. These fatty acids from RJ exhibit weak ER binding activity and bind preferentially to ER, which shows moderate expression in rat uterus comparing with ER (Kuiper et al., 1997) . Other estrogenic isoflavonoids, such as genistein, which also exhibits higher affinity to ER than ERshowprostate cancer risk reducing effect (McCarty, 2006) . Genistein is able to inhibit estrogen-induced proliferation (Liu et al., 2002) and down-regulate androgen receptor expression (Bektic et al., 2004) mediated by ERBecause of the structural similarity, the identified E-dec-2-enedioic acid supposedly binds to the ER, but further investigations are required to determine which ER subtype is responsible for the estrogenic effect of DM. The molecule is known in scientific literature, because it was found as a major mandibular gland component in queen and worker dwarf honey bees (Keeling et al., 2000) , but it has not been found in honey bee products. The biosynthesis of this compound and other similar bee mandibular pheromones and fatty acids are also known (Plettner et al., 1998) .
Evidence of a gestagenic effect of drone milk
There have been literature reports that certain honey bee products exert a gestagenic effect besides estrogenic activity. Kridli & Al-Khetib (2006) described that RJ with an unambiguous estrogenic effect elevated the plasma P level in pregnant sheep. We therefore set out to determine whether raw DM is capable of such a gestagenic effect.
Crude DM proved to enhance the fetal survival rate in the pregnancy maintenance assay.
Although this effect was not significant, it did suggest some weak gestagen-like activity. To confirm this putative gestagenic effect, molecular techniques were used. It is known that the mRNA level of CRLR is increased by gestagens in ovariectomized rats or during pregnancy.
Estrogens can also influence the expression of CRLR: they decrease this expression, but their joint effect shifts from estrogenic activity to gestagenic activity. This means that a combination of estrogen and P will increase the CRLR expression (Thota et al., 2003) . RT-PCR measurements showed that crude DM, similarly to P, increased the mRNA expression of CRLR. The Western blot investigations also confirmed the results of RT-PCR measurements; raw DM enhanced the protein level of CRLR in rat uterine tissues. During RT-PCR experiments, we found that, in contrast with DM the weak gestagen SP alone, did not increase the mRNA expression of CRLR, but its combination with DM gave rise to a significantly higher mRNA level of CRLR. The combination exhibited a threefold higher gestagenic effect than that of crude DM.
Our results clearly show that crude DM elicits a gestagenic effect when it is combined with another weak gestagenic compound, but the mechanism of action is still unknown. The gestagenic compound(s) in DM probably enhance(s) the sexual hormone levels and/or has/have a direct hormonal effect. Another possible explanation is that the identified androgenic or estrogenic compounds in DM may exert a weak gestagenic effect, too.
Conclusions
We found that the hitherto unknown DM exhibits significant sexual hormonal effects in both male and female rats. DM displays marked androgenic activity in castrated male rats. We identified the compounds MP and MO which are responsible for its androgenic effect. The exact mechanisms of action of MP and MO are still unknown, but reports in the scientific literature suggest that they are involved in steroidogenesis. Male infertility is an emerging health problem; it is currently responsible for approximately 20% of all human infertility cases (O'Flynn O'Brien et al., 2010) . The fact that crude DM or MP or/and MO treatments are able to increase the weights of androgen-sensitive organs without exerting an accompanying anabolic effect may project a new, natural mode for the therapy of fertility problems in men.
DM clearly shows an estrogenic effect in female rats. E-dec-2-enedioic acid, an estrogenic compounds isolated from crude DM, exhibits structural similarity to the estrogenic compounds of RJ, which are able to bind to the ER. In view of the structural similarity, E-dec-2-enedioic acid presumably likewise binds to the ER. The estrogenic activity of DM justifies its use in folk medicine and may lead to new possibilities for its use in estrogen-deficient conditions in women, similarly to RJ.
The identified compounds with hormonal effects (MP, MO and E-dec-2-enedioic acid) differ considerably from the well-known ecdysteroids of insects. Although both DM compounds and ecdysteroids are isolated from insects and exert pharmacological effects on mammals, the DM compounds have non-steroidal structures and well-defined androgenic or estrogenic activities without any anabolic effect.
Raw DM elicits not only androgenic and estrogenic activities, but also a weak gestagenic effect, which becomes relevant in combination with another weak gestagen. The mechanism of this action and the gestagenic compound(s) of DM are still unknown, but the identified androgenic or estrogenic compounds of DM may be responsible for this weak gestagenic activity.
